Michel Michailidis

Michel Michailidis is a prominent ophthalmology professor at the UCL Institute of Ophthalmology in London. He has been at the forefront of groundbreaking research in gene therapy, particularly in the treatment of rare genetic conditions affecting vision. His recent work has focused on a revolutionary gene therapy that successfully restored sight in children suffering from Leber Congenital Amaurosis, a severe inherited form of blindness. Michailidis emphasizes the transformative potential of gene therapy, highlighting its ability to significantly improve the quality of life for affected individuals and set new standards for early treatment interventions.